HeartFlow, Inc. is a medical technology company focused on enhancing the diagnosis and management of coronary artery disease, which remains the leading cause of death globally. The company's hallmark offering, the HeartFlow FFRCT Analysis, utilizes advanced AI-driven technology to produce a detailed, color-coded 3D model of a patient's coronary arteries. This model helps healthcare professionals understand how blockages affect blood flow, thereby aiding in more accurate diagnoses and treatment planning. HeartFlow's integrated heart care solutions assist clinicians in identifying arterial stenoses, assessing coronary blood flow, and quantifying plaque buildup. With a growing pipeline of products and a commitment to improving precision heart care, HeartFlow has gained international recognition and has supported over 250,000 patients worldwide. The company emphasizes a culture of continuous improvement and teamwork, striving to revolutionize cardiovascular healthcare while upholding values of innovation, quality, and patient-centric care.